Morgan Stanley Initiates Coverage On Organogenesis Hldgs with Equal-Weight Rating, Announces Price Target of $5
Portfolio Pulse from richadhand@benzinga.com
Morgan Stanley analyst Drew Ranieri initiates coverage on Organogenesis Holdings (NASDAQ:ORGO) with an Equal-Weight rating and a price target of $5.
June 15, 2023 | 10:25 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley initiates coverage on Organogenesis Holdings with an Equal-Weight rating and a price target of $5.
Morgan Stanley's initiation of coverage on Organogenesis Holdings with an Equal-Weight rating suggests a neutral outlook for the stock. The price target of $5 indicates the analyst's expectation for the stock's performance. This news is directly related to ORGO and is important for investors, but the neutral rating suggests no significant short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100